跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71 条关于
“Heidelburg”
全部
71
临床试验
28
药物
17
机构
12
资讯
14
去年
Munich to Host Clinical Trials in Oncology Europe 2024: AI Strategy and Patient Experience Take Center Stage
去年
Heidelberg Pharma's HDP-101 Shows Promise in Relapsed Multiple Myeloma
9个月前
Heidelberg Pharma Appoints Dr. Dongzhou Jeffery Liu as New CEO Amid Leadership Transition
去年
Heidelberg Pharma to Showcase Novel ADC Technologies Targeting Gastrointestinal Cancers at AACR 2025
6个月前
Heidelberg Pharma Advances Novel ATAC Technology Platform with Multiple Cancer Candidates in Clinical Development
11个月前
Heidelberg Pharma's HDP-101 ADC Receives FDA Fast Track Designation for Multiple Myeloma Treatment
6个月前
Heidelberg Pharma Secures $45 Million Through Modified Licensing Agreement with HealthCare Royalty and Soleus Capital
去年
Heidelberg Pharma Advances into Cohort 7 in Phase I/IIa Study for Multiple Myeloma Treatment
22天前
Heidelberg Pharma and Huadong Medicine Expand Partnership to Co-Develop Next-Generation Antibody Drug Conjugates
去年
Heidelberg Pharma Secures $20 Million in Amended Royalty Deal with HealthCare Royalty for Renal Cancer Diagnostic
第 1 页,共 2 页
上一页
下一页